ATM and Obesity: Intriguingly, an intraperitoneal injection of butyrate in db/db mice markedly reduced the expression of inflammatory factors in subcutaneous adipose tissue and improved obesity-triggered IR in conjunction with the decreased expression of inflammatory ATM marker genes (67).